Cardiac amyloidosis: A case report and therapeutic implications

Heart Disease

Volumn 4, Issue 2, 2002, Pages 86-90

  Kotha, Anu Radha ^a   Weiss, Melvin B ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLCHICINE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOLIC ACID; FUROSEMIDE; IRON; MELPHALAN; PREDNISONE;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG RESPONSE; HEART AMYLOIDOSIS; HUMAN; IMMUNOELECTROPHORESIS; KIDNEY FUNCTION; MALE; PROGNOSIS; REMISSION; SEPSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0036120513     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200203000-00005     Document Type: Article

References (36)

1. Amyloidosis Recognition, prognosis and therapy
2. Amyloidosis prognosis and treatment
3. Primary systemic amyloidosis- a diagnostic primer
4. Amyloidosis
5. Ethnic distribution of amyloidosis: An autopsy study
6. Variant sequence transthyretin (iso[eucine 122) in late onset cardiac amyloidosis in black Americans
7. Cardiac amyloidosis causing cardiac dysfunction. Analysis of 54 necropsy patients
8. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis
9. The cardiomyopathies and myocarditis
10. The conduction system in cardiac amyloidosis
11. Electrophysiological abnormalities in AL (primary) amyloidosis with cardiac involvement
12. Signal averaged electrocardiography in patients with AL (primary) amyloidosis
13. QT interval in cardiac amyloidosis
14. Echocardiographic observations in patients with systemic infiltrative disease involving the heart
15. Serial echocardiographic observations in patients with primary systemic amyloldosis: An introduction to the concept of early (asymptomatic) amyloid infiltration of the heart
16. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis
17. Myocardial texture charactcrization by two-dimensional echocardiography
18. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis
19. Serial Doppler echocardiographic follow up of left ventricular diastolic function in cardiac amyloidosis
20. Comprehensive doppler assessment of right ventricular diastolic function in cardiac amyloidosis
21. Right ventricular dilation in primary amyloidosis: An independent predictor of survival
22. Utility of technitium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis
23. Is technetium 99-m pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis
24. Amyloid cardiomyopathy: Characterization by a distinctive voltage/mass relationship
25. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement
26. Cardiac immunocyte derived amyloidosis: An endomyocardial biopsy study in 11 patients
27. Amyloidosis (AL). Clinical and laboratory features in 229 cases
28. Left veritricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis
29. Cardiac amyloidosis with asymmetric septal hypertrophy and deterioration after nifedipine
30. Primary systemic amyloidosis: Comparison of melphalan and prednisone versus placebo
31. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine
32. Resolution of heart failure in patients with AL amyloidosis
33. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis
34. Cardiac transplantation for AL amyloidosis
35. Digoxin sensitivity in amyloid cardiomyopathy
36. Pathology of cardiac conduction system in amyloidosis